Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials
نویسندگان
چکیده
In many clinical trials, longitudinal or repeated measures data is collected in order to monitor the patient’s progress over time towards a clinical end-point. One method of accounting for the two outcomes is by using joint modelling methods. However, little work has been done on sample size calculations for studies which use joint modelling of longitudinal and time-to-event data to establish treatment effects. We propose a sample size formula based on the random effects formulation of the joint model. The method calculates the sample size and power based on the number of longitudinal time points by extending the Schoenfeld [1] approach to sample size for the proportional hazards model. We derive the required number of events using the score statistic [2] based on the random effects joint model [3].
منابع مشابه
Bayesian Sample Size Determination for Joint Modeling of Longitudinal Measurements and Survival Data
A longitudinal study refers to collection of a response variable and possibly some explanatory variables at multiple follow-up times. In many clinical studies with longitudinal measurements, the response variable, for each patient is collected as long as an event of interest, which considered as clinical end point, occurs. Joint modeling of continuous longitudinal measurements and survival time...
متن کاملمدلسازی توام دادههای بقا و طولی و کاربرد آن در بررسی عوامل موثر بر آسیب حاد کلیوی
Background: In many clinical trials and medical studies, the survival and longitudinal data are collected simultaneously. When these two outcomes are measured from each subject and the survival variable depends on a longitudinal biomarker, using joint modelling of survival and longitudinal outcomes is a proper choice for analyzing the available data. Methods: In this retrospective archiv...
متن کاملDesign Considerations for Complex Survival Models
LIDDY MIAOLI CHEN: DESIGN CONSIDERATIONS FOR COMPLEX SURVIVAL MODELS. (Under the direction of Dr. Joseph G. Ibrahim and Dr. Haitao Chu.) Various complex survival models, such as joint models of survival and longitudinal data and multivariate frailty models, have gained popularity in recent years because these models can maximize the utilization of information collected. It has been shown that t...
متن کاملکاربرد مدل توأم بقا و داده های طولی در بیماران دیالیز صفاقی
Background and Aim: In many medical studies along with longitudinal data, which are repeatedly measured during a certain time period, survival data are also recorded. In these situations, using models such as, mixed effects models or GEE method for longitudinal data and Cox model for survival data, are not appropriate because some necessary assumptions are not met. Instead, the joint models hav...
متن کاملCharacteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in IRCT
Background and Objectives: A considerable number of clinical trials are conducted in Iran each year. Not much is known about the characteristics of them, this study aimed to investigate key characteristics of Iranian clinical trials. Methods: All clinical trial protocols registered in IRCT until November 2013 were selected. Text mining techniques were used to extract information from data t...
متن کامل